Home / World news / Medicines & vaccines
Medicines & vaccines

The US speeds up approval of medicines for cattle, pigs and poultry: an FDA pilot cuts two years from residue testing for meat, milk and eggs

On 27 October the FDA's Center for Veterinary Medicine launched a voluntary pilot programme: makers of new medicines for food-producing animals will be able to show more quickly that drug residues in meat, milk, eggs and honey can be reliably detected in a government laboratory. The FDA estimates this will save around two years. We explain what's changing, why residues are tested at all and how it works in the UK and Europe — including for people keeping hens and horses.

8 min read
Cow standing in a pasture
Photo: Freepik
Contents
  1. What the FDA has launched
  2. How it worked before
  3. What's changing
  4. Why it matters
  5. How long the pilot will run
  6. Why residues are tested at all
  7. Why antibiotics get special attention
  8. What this means for Europe
  9. What backyard hen keepers need to know
  10. What horse owners need to know
  11. How keepers of food-producing animals can follow the rules
  12. What happens next
  13. When to see a vet

What the FDA has launched

On 27 October 2026 the Center for Veterinary Medicine (CVM) of the US Food and Drug Administration (FDA) announced a new voluntary pilot programme. It concerns medicines for food-producing animals — those that give us meat, milk, eggs and honey: cattle, pigs, poultry, sheep, goats, fish and bees.

Under US law, the maker of a new veterinary medicine for such animals must provide a "practicable" analytical method — a way of detecting the medicine's residues in food. The FDA defines such a method as valid, reproducible and usable in a government laboratory. The new programme is meant to simplify and speed up proving that a method meets these requirements.

Key figuresFDA residue pilot
about 2 yearstaken by the old interlaboratory trial of a methodthe new approach replaces it
3risk tiers for testing methodsnegligible, low, moderate
about 2 yearssaved, by the FDA's estimateacross the whole residue evaluation
3medicines must complete tier 2 or 3one of the conditions for ending the pilot

FDA, Center for Veterinary Medicine; 27 October 2026

How it worked before

To prove that an analytical method works, a manufacturer usually had to run an interlaboratory trial: the same method was tested in several laboratories and the results compared. According to the FDA, such a trial took around two years on average. If the method was later modified, a separate validation study was needed for the modified version — causing further delays.

What's changing

Under the pilot, each analytical method is placed in one of three risk tiers:

  1. Tier 1 — negligible risk. The method is very close to ones the FDA and the US Department of Agriculture (USDA) already trust.
  2. Tier 2 — low risk.
  3. Tier 3 — moderate risk.

The principle is simple: the closer a method is to proven ones, the lower its tier and the fewer steps needed to demonstrate that it's fit for purpose.

The key innovation is one study instead of several. The manufacturer carries out a single method validation, and its results serve two purposes at once: for the study of how quickly the drug is cleared from the animal's body, and as the basis for the method government laboratories will later use. This removes the need for a separate validation and, in many cases, a separate animal study. The FDA has published a companion document on this "one method" approach.

Why it matters

By the FDA's estimate, the new approach could shorten the whole residue evaluation by about two years. That means new medicines for cattle, pigs and poultry will reach vets faster. The programme came out of agreements between the FDA and industry when the animal drug user fee law (ADUFA V) was reauthorised in 2024. Avoiding unnecessary animal studies is another benefit that regulators and animal welfare groups alike talk about today.

For vets and farmers this matters because there are few medicines for food-producing animals. Developing a new product is expensive, the market for each species is small, and manufacturers often drop projects because of long, costly testing. Every year saved makes development more worthwhile and increases the chance that new treatments appear at all — for example, for diseases that currently have almost no treatment options.

How long the pilot will run

The programme will run until whichever comes first: at least three new medicines completing the tier 2 or tier 3 process, or the end of the next user fee period (ADUFA VI), if it is reauthorised. The FDA advises manufacturers to contact the Center for Veterinary Medicine as early as possible in development to save the most time. The pilot documents may be updated.

Why residues are tested at all

When a cow, pig or hen is given a medicine, some of it stays in the body for a while — in muscle, liver, kidneys and fat, and in milk and eggs. If the food reaches people too soon, they eat drug residues along with it. Usually these are tiny amounts, but some substances can cause allergies, and antibiotic residues encourage bacterial resistance.

So for every medicine for food-producing animals, a permitted level of residues in food is set, along with a withdrawal period — the time after the last dose during which meat, milk or eggs must not be used as food. Government laboratories test food at random to make sure the rules are followed. For that, they need a reliable analytical method from the manufacturer.

Why antibiotics get special attention

Among medicines for food-producing animals, antibiotics attract the most attention. Antibiotic residues in milk stop cheese and yoghurt from being made: the starter cultures don't work because their bacteria die. But the main concern is resistance. When small amounts of antibiotics get into the environment and into people, the most resistant microbes survive, and infections become harder to treat in both animals and humans.

That's why dairies test milk for antibiotics in almost every collection, and farmers who break withdrawal periods face penalties and lost income. The reliable analytical methods at the heart of the FDA pilot are the foundation of this whole control system.

What this means for Europe

The EU's system is set up differently, but the aim is the same. Maximum residue limits for veterinary medicines in food are set for the whole EU on the basis of scientific opinions from the European Medicines Agency (EMA). A medicine for food-producing animals can't be authorised until such a limit has been set for its active substance. In Great Britain, the Veterinary Medicines Directorate (VMD) runs an equivalent system. The withdrawal period is stated on the label of every medicine, and the vet must tell the animal's owner what it is.

Every year, EU countries test meat, milk, eggs and honey for drug residues under national control plans, and in the UK the VMD runs a national residue surveillance programme, using official and reference laboratories. The FDA pilot doesn't directly affect European rules, but it could speed up new medicines that are later authorised in Europe too. International requirements for validating analytical methods are largely shared through the VICH programme, in which regulators from the US, the EU and Japan work together, and the FDA's programme cites its guideline.

What backyard hen keepers need to know

Many people keep a few hens for their own eggs. For them, withdrawal periods apply just as they do on a farm: a hen is a food-producing animal. If your vet prescribes a medicine for your hens, always ask how many days you mustn't eat the eggs or meat, and stick to it. Some products aren't permitted at all for hens laying eggs for eating. Never treat hens with medicines meant for cats and dogs or with human tablets: no withdrawal periods have been set for them, and they can be dangerous to poultry.

What horse owners need to know

In the EU and the UK, a horse is treated as a food-producing animal by default, even if nobody intends it to go for slaughter. The horse passport has a section where the owner can declare that the horse is permanently excluded from the human food chain. That declaration affects which medicines can be used: for horses that haven't been excluded, some products are banned or require a long withdrawal period. So if your vet asks about the passport before treatment, it isn't just a formality. The decision to exclude a horse from the food chain can't be reversed, so it's worth discussing with your vet in advance.

How keepers of food-producing animals can follow the rules

  • Record every treatment: date, product, batch number and withdrawal period — keeping these records is a legal requirement.
  • Use only medicines prescribed by your vet, exactly as directed.
  • Observe the withdrawal period for meat, milk and eggs — even if the animal looks healthy.
  • Mark treated animals so you don't milk a cow or collect eggs too early by mistake.
  • Store medicines separately and out of reach of children and animals.

What happens next

The FDA will take applications from manufacturers to join the pilot and decide, based on the results, whether to make the new approach permanent. If it proves its worth, new veterinary medicines for cattle, pigs, poultry and other food-producing animals will become available faster in the US. For vets and farmers in the UK and Europe, this could mean new medicines reaching authorisation sooner here too. Food safety rules aren't being relaxed: what changes is only how a manufacturer proves a method is reliable, not the requirements for residues.

When to see a vet

If your cow, goat, hen or horse is unwell, treatment must be prescribed by a vet — they'll choose a product authorised for that species and tell you what withdrawal period applies to milk, eggs and meat. Don't give food-producing animals medicines without a prescription, and don't change the dose or length of treatment yourself.

Sources

  1. FDA, Center for Veterinary Medicine (CVM), 27 October 2026